Sartor AO, la Fougere C, Essler M, Ezziddin S, et al. Lutetium-177-prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience. J Nucl Med 2021 Jun 24. pii: jnumed.121.262240. doi: 10.2967/jnumed.121.262240.
PMID: 34168015